Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal adenocarcinoma

被引:3
作者
Liu, Xiaomeng [1 ,2 ,3 ,4 ]
Liu, Jiang [1 ,2 ,3 ,4 ]
Xu, Jin [1 ,2 ,3 ,4 ]
Zhang, Bo [1 ,2 ,3 ,4 ]
Wei, Miaoyan [1 ,2 ,3 ,4 ]
Li, Jialin [1 ,2 ,3 ,4 ]
Xu, Hang [1 ,2 ,3 ,4 ]
Yu, Xianjun [1 ,2 ,3 ,4 ]
Wang, Wei [1 ,2 ,3 ,4 ]
Shi, Si [1 ,2 ,3 ,4 ]
机构
[1] Fudan Univ Shanghai, Dept Pancreat Surg, Canc Ctr, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
[3] Shanghai Pancreat Canc Inst, Shanghai 200032, Peoples R China
[4] Fudan Univ, Pancreat Canc Inst, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
Pancreatic cancer; Adipocyte infiltration; Cytokine infiltration; Antitumor immune response; Tumor microenvironment; ADIPOSE-TISSUE; CANCER; OBESITY; MICROENVIRONMENT; INFLAMMATION; CROSSTALK;
D O I
10.1016/j.tranon.2022.101561
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic ductal adenocarcinoma (PDAC) is a highly fatal malignancy that is characterized by an immuno-suppressive microenvironment. The immune suppression in PDAC is largely driven by heterogeneous stromal and tumor cells. However, how adipocyte in the tumor microenvironment (TME) is related to the immune cell infiltration in PDAC has rarely been published. We identified adipocytes by performing bioinformatics analyses, and explored the clinical outcomes and TME characters in PDAC with different levels of adipocyte infiltration. Interestingly, in contrast to adiposity, high adipocyte infiltration in the TME was related to significantly increased median overall survival and a lower total tumor mutational burden. Functionally, high adipocyte infiltration was associated with the immune response, particularly with the abundant cytokine infiltration in PDAC samples. Moreover, adipocyte infiltration in the TME was positively associated with anticancer signatures in the immune microenvironment. Immunohistochemistry and RT-PCR were performed with PDAC tissue sam-ples from our center to study the expression of adipocytes in PDAC. The mature adipocytes were strongly associated with the immune composition and prognosis of patients with PDAC. Primary adipocytes were isolated from mice to construct a PDAC transplantation tumor model. In vivo experiments showed that adipocytes elicited increased CD8+ T cell infiltration and potent antitumor activity in tumor-bearing mice. Overall, we innovatively found that adipocytes facilitated the antitumor immune response in the TME by performing mouse experiments and analyzing PDAC samples. This study provides a new perspective on the activation of the immune micro -environment in PDAC.
引用
收藏
页数:13
相关论文
共 38 条
[1]   Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies [J].
Anderson, Kristin G. ;
Stromnes, Ingunn M. ;
Greenberg, Philip D. .
CANCER CELL, 2017, 31 (03) :311-325
[2]   xCell: digitally portraying the tissue cellular heterogeneity landscape [J].
Aran, Dvir ;
Hu, Zicheng ;
Butte, Atul J. .
GENOME BIOLOGY, 2017, 18
[3]   Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 [J].
Barbie, David A. ;
Tamayo, Pablo ;
Boehm, Jesse S. ;
Kim, So Young ;
Moody, Susan E. ;
Dunn, Ian F. ;
Schinzel, Anna C. ;
Sandy, Peter ;
Meylan, Etienne ;
Scholl, Claudia ;
Froehling, Stefan ;
Chan, Edmond M. ;
Sos, Martin L. ;
Michel, Kathrin ;
Mermel, Craig ;
Silver, Serena J. ;
Weir, Barbara A. ;
Reiling, Jan H. ;
Sheng, Qing ;
Gupta, Piyush B. ;
Wadlow, Raymond C. ;
Le, Hanh ;
Hoersch, Sebastian ;
Wittner, Ben S. ;
Ramaswamy, Sridhar ;
Livingston, David M. ;
Sabatini, David M. ;
Meyerson, Matthew ;
Thomas, Roman K. ;
Lander, Eric S. ;
Mesirov, Jill P. ;
Root, David E. ;
Gilliland, D. Gary ;
Jacks, Tyler ;
Hahn, William C. .
NATURE, 2009, 462 (7269) :108-U122
[4]   Challenges and Opportunities for Pancreatic Cancer Immunotherapy [J].
Bear, Adham S. ;
Vonderheide, Robert H. ;
O'Hara, Mark H. .
CANCER CELL, 2020, 38 (06) :788-802
[5]   Understanding the tumor immune microenvironment (TIME) for effective therapy [J].
Binnewies, Mikhail ;
Roberts, Edward W. ;
Kersten, Kelly ;
Chan, Vincent ;
Fearon, Douglas F. ;
Merad, Miriam ;
Coussens, Lisa M. ;
Gabrilovich, Dmitry I. ;
Ostrand-Rosenberg, Suzanne ;
Hedrick, Catherine C. ;
Vonderheide, Robert H. ;
Pittet, Mikael J. ;
Jain, Rakesh K. ;
Zou, Weiping ;
Howcroft, T. Kevin ;
Woodhouse, Elisa C. ;
Weinberg, Robert A. ;
Krummel, Matthew F. .
NATURE MEDICINE, 2018, 24 (05) :541-550
[6]   A role for novel adipose tissue-secreted factors in obesity-related carcinogenesis [J].
Cabia, B. ;
Andrade, S. ;
Carreira, M. C. ;
Casanueva, F. F. ;
Crujeiras, A. B. .
OBESITY REVIEWS, 2016, 17 (04) :361-376
[7]   Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma [J].
Aguirre, Andrew J. ;
Hruban, Ralph H. ;
Raphael, Benjamin J. .
CANCER CELL, 2017, 32 (02) :185-+
[8]   The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study [J].
Carreras-Torres, Robert ;
Johansson, Mattias ;
Gaborieau, Valerie ;
Haycock, Philip C. ;
Wade, Kaitlin H. ;
Relton, Caroline L. ;
Martin, Richard M. ;
Smith, George Davey ;
Brennan, Paul .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (09)
[9]   FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer [J].
Conroy, T. ;
Hammel, P. ;
Hebbar, M. ;
Ben Abdelghani, M. ;
Wei, A. C. ;
Raoul, J. -L. ;
Chone, L. ;
Francois, E. ;
Artru, P. ;
Biagi, J. J. ;
Lecomte, T. ;
Assenat, E. ;
Faroux, R. ;
Ychou, M. ;
Volet, J. ;
Sauvanet, A. ;
Breysacher, G. ;
Di Fiore, F. ;
Cripps, C. ;
Kavan, P. ;
Texereau, P. ;
Bouhier-Leporrier, K. ;
Khemissa-Akouz, F. ;
Legoux, J. -L. ;
Juzyna, B. ;
Gourgou, S. ;
O'Callaghan, C. J. ;
Jouffroy-Zeller, C. ;
Rat, P. ;
Malka, D. ;
Castan, F. ;
Bachet, J. -B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (25) :2395-2406
[10]   Obesity, Inflammation, and Cancer [J].
Deng, Tuo ;
Lyon, Christopher J. ;
Bergin, Stephen ;
Caligiuri, Michael A. ;
Hsueh, Willa A. .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11, 2016, 11 :421-449